IP Library Granted Patent US 11,957,904
Granted Patent B2
US 11,957,904 · App. 17/366,741 · Granted Apr 16, 2024

Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields

Inventors: Peter F. Travers (Longwood, FL); Ken Watkins (Lake Mary, FL); Scott Krywick (Clermont, FL); Matthew Travers (Apopka, FL)
Assignee: LifeBridge Innovations, PBC
A61N1/36002A61N1/0476A61N1/36014A61N1/36185A61N1/37217A61N1/40A61N1/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,957,904
App. No.
17/366,741
Granted
Apr 16, 2024
Kind
B2
Abstract

A method of using an electrode array to deliver tumor treating electric fields to a patient including the steps of: placing a plurality of electrode elements in optimized locations on the patient, each of the electrode elements being independently programmable, the optimized locations are optimized relative to a target area wherein at least one tumor is located; programming a control device with a frequency range, a firing configuration and a firing sequence for the plurality of electrode elements; and generating electrical signals in the frequency range, the electrical signals being directed to at least two of the plurality of electrode elements in a sequence determined by the firing sequence.

Claims (27)

1. A method of using an electrode array to deliver tumor treating electric fields to a patient, comprising the steps of:

placing a plurality of electrode elements in optimized locations on the patient, each of the electrode elements being independently programmable;

programming a control device with a frequency range, a firing configuration and a firing sequence for the plurality of electrode elements;

generating electrical signals with a field generator in the frequency range, the electrical signals being directed to at least two of the plurality of electrode elements, wherein the plurality of electrode elements include at least one master electrode element and a plurality of slave electrode elements, the firing configuration of the slave electrode elements coupled to the at least one master electrode element is controlled by the at least one master electrode element by directing the electrical signals from the field generator to selected ones of the slave electrode elements; and

the master electrode element directing at least one of the slave electrode elements to fire active or be a return, the master electrode element having a microprocessor and at least one light emitting diode placed thereon, but the slave electrode elements not having a microprocessor nor a light emitting diode thereon.

2. The method of claim 1 , further comprising the step of maintaining a minimum electric field strength in a target area associated with a tumor in the patient.

3. The method of claim 2 , wherein the minimum electric field strength is maintained by the firing configuration and the firing sequence of the plurality of electrode elements.

4. The method of claim 2 , wherein the optimized locations of the electrode elements in combination with the firing sequence maintain the minimum electric field strength.

5. The method of claim 4 , wherein the minimum electric field strength is 1V/cm.

6. The method of claim 4 , wherein the minimum electric field strength is 2V/cm.

7. The method of claim 4 , wherein the firing configuration is conveyed to the at least one master electrode element from the control device.

8. The method of claim 1 , wherein the at least one master electrode element can deliver the electric signal to the patient.

9. The method of claim 1 , wherein a combination of the master electrode elements and the slave electrode elements deliver the electric signal to the patient.

10. A method of using an electrode array to deliver tumor treating electric fields to a patient, comprising the steps of:

placing a plurality of electrode elements in optimized locations on the patient, each of the electrode elements being independently programmable, the optimized locations are selected relative to a target area wherein at least one tumor is located, the plurality of electrode elements including at least one master electrode element and a plurality of slave electrode elements;

programming a control device with a frequency range, a firing configuration and a firing sequence for the plurality of electrode elements;

generating electrical signals in the frequency range, the electrical signals being directed to at least two of the plurality of electrode elements in a sequence determined by the firing sequence;

controlling the firing configuration of the slave electrode elements that are coupled to the at least one master electrode element by the at least one master electrode element directing the electrical signals from a field generator to selected ones of the slave electrode elements; and

the master electrode element directing at least one of the slave electrode elements to fire active or be a return, the master electrode element having a microprocessor and at least one light emitting diode placed thereon, but the slave electrode elements not having a microprocessor nor a light emitting diode thereon.

11. The method of claim 10 , further comprising the step of maintaining a minimum electric field strength in the target area associated with the tumor in the patient.

12. The method of claim 11 , wherein the minimum electric field strength is maintained by the firing configuration and the firing sequence of the plurality of electrode elements.

13. The method of claim 11 , wherein the optimized locations of the electrode elements in combination with the firing sequence maintain the minimum electric field strength.

14. The method of claim 13 , wherein the minimum electric field strength is 1V/cm.

15. The method of claim 13 , wherein the minimum electric field strength is 2V/cm.

16. The method of claim 13 , wherein the firing configuration is conveyed to at least one master electrode element from the control device.

17. The method of claim 10 , wherein the at least one master electrode element can deliver the electric signal to the patient.

18. The method of claim 10 , wherein a combination of the master electrode elements and the slave electrode elements deliver the electric signal to the patient.

Assignments (1)
MERGER Recorded Jul 28, 2022
From: LOYALTY BASED INNOVATIONS, LLC; LIFEBRIDGE 10000, LLC
To: LIFEBRIDGE INNOVATIONS, PBC
Reel/Frame 060655/0172 →
Continuity (5)
Division 16177913 · Nov 1, 2018
Continuation In Part 15826112 · Nov 29, 2017
Division 14795597 · Jul 9, 2015
Provisional Application 62028996 · Jul 25, 2014
Related Publication 20220001172A1 · Jan 6, 2022